Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY-NC 4.0Gut Microbes

Surface-functionalized Bifidobacterium bifidum alleviates Clostridioides difficile infection by coordinating host immune modulation and gut microbiota restoration☆

  1. 1College of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi Province, China
  2. 2Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

Abstract

Clostridioides difficile infection (CDI) is a major ecological disruption of the gut ecosystem, characterized by loss of colonization resistance, persistent inflammatory feedback and incomplete microbial recovery. Meta-analysis of clinical cohorts identified Bifidobacterium depletion as a conserved feature of CDI-associated dysbiosis, suggesting that restoring this genus may promote recovery from CDI. Comparative in vitro assays identified B. bifidum as the most protective strain. This effect was not attributable to direct inhibition of C. difficile growth, but instead was associated with strong adhesion to intestinal mucus and epithelial cells and direct competition for epithelial attachment sites. However, B. bifidum alone was insufficient to counteract host inflammation and showed limited survival during gastrointestinal transit. To address these constraints, we integrated B. bifidum with β-hydroxybutyrate (BHB) to mitigate inflammation-associated habitat filtering and applied an outer hyaluronic-acid (HA) coating to protect B. bifidum viability and confer preferential targeting to the colon and inflamed mucosa. This sequential strategy, termed BB@PCB-HA, markedly alleviated inflammation and restored epithelial barrier integrity, microbial community structure and metabolic function in both CDI and recurrent CDI mouse models. These findings advance probiotic therapy from strain supplementation to programmable functionalized microecological intervention, providing a new paradigm for treating CDI and other gastrointestinal diseases.

Related

  1. A stratified cell sheet platform coordinating dual osteogenic and chondrogenic differentiation for osteochondral tissue engineering.
    Fatemeh Leisi Mehrabani, Samaneh Hosseini, Mohamadreza Baghaban Eslaminejad
    Biomedical engineering onlinePeer-reviewedCC BY-NC-NDFull textHuman geneticsEurope PMCPMC
  2. GPR87 protects UVB-damaged skin by coordinating antioxidant, DNA repair, and anti-inflammatory responses via Nrf2 and PI3K/AKT–NF-κB pathways
    Kai Zang, Biao Guo, Jia-Hui Yu +5
    Zoological ResearchPeer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
  3. Mini‐Mental State Examination trajectories across dementia subtypes in the Swedish Registry for Cognitive/Dementia Disorders and U.S. National Alzheimer's Coordinating Center
    Xinqi Bao, Belén García Pascual, Eirik Blakstad +9
    Alzheimer's & Dementia : Diagnosis, Assessment & Disease MonitoringPeer-reviewedCC BY 4.0Full textPsychiatry & mental healthPMC
  4. Coordinating extreme-heat adaptation at mega-sporting events: early warning and cost sharing in a multi-actor differential game
    Jiaxin Zhang, Siqing Zhang, Junrong Lei
    Frontiers in public healthPeer-reviewedCC BYFull textPhysiologyEurope PMCCrossref
  5. Epidemiology, risk factors and outcomes of Clostridioides difficile infection in a UK district general hospital: a retrospective cohort study
    Pushpa Saajan, Shayi Shali, Kimberly Rose Cabiles +2
    Infection prevention in practicePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
BibTeX
@article{yang2026surfacefunctionalized,
  title = {{Surface-functionalized Bifidobacterium bifidum alleviates Clostridioides difficile infection by coordinating host immune modulation and gut microbiota restoration☆}},
  author = {Hao Yang and Weibin Wu and Lamei Wang and Rui Zhang and Javier A. Villafuerte Gálvez and Ruiting Zhang and Junhu Yao and Xinhua Chen and Shengru Wu and Yangchun Cao},
  journal = {Gut Microbes},
  year = {2026},
  month = nov,
  doi = {10.1080/19490976.2026.2756797},
  url = {https://doi.org/10.1080/19490976.2026.2756797},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Surface-functionalized Bifidobacterium bifidum alleviates Clostridioides difficile infection by coordinating host immune modulation and gut microbiota restoration☆
AU  - Hao Yang
AU  - Weibin Wu
AU  - Lamei Wang
AU  - Rui Zhang
AU  - Javier A. Villafuerte Gálvez
AU  - Ruiting Zhang
AU  - Junhu Yao
AU  - Xinhua Chen
AU  - Shengru Wu
AU  - Yangchun Cao
PY  - 2026
DA  - 2026/11/04
JO  - Gut Microbes
DO  - 10.1080/19490976.2026.2756797
UR  - https://doi.org/10.1080/19490976.2026.2756797
AB  - Clostridioides difficile infection (CDI) is a major ecological disruption of the gut ecosystem, characterized by loss of colonization resistance, persistent inflammatory feedback and incomplete microbial recovery. Meta-analysis of clinical cohorts identified Bifidobacterium depletion as a conserved feature of CDI-associated dysbiosis, suggesting that restoring this genus may promote recovery from CDI. Comparative in vitro assays identified B. bifidum as the most protective strain. This effect was not attributable to direct inhibition of C. difficile growth, but instead was associated with strong adhesion to intestinal mucus and epithelial cells and direct competition for epithelial attachment sites. However, B. bifidum alone was insufficient to counteract host inflammation and showed limited survival during gastrointestinal transit. To address these constraints, we integrated B. bifidum with β-hydroxybutyrate (BHB) to mitigate inflammation-associated habitat filtering and applied an outer hyaluronic-acid (HA) coating to protect B. bifidum viability and confer preferential targeting to the colon and inflamed mucosa. This sequential strategy, termed BB@PCB-HA, markedly alleviated inflammation and restored epithelial barrier integrity, microbial community structure and metabolic function in both CDI and recurrent CDI mouse models. These findings advance probiotic therapy from strain supplementation to programmable functionalized microecological intervention, providing a new paradigm for treating CDI and other gastrointestinal diseases.
SN  - 1949-0976
SN  - 1949-0984
ER  -